Yokomichi, Hiroshi http://orcid.org/0000-0001-7369-155X
Tanaka-Taya, Keiko
Koshida, Rie
Nakano, Takashi
Yasui, Yoshinori
Mori, Masaaki
Ando, Yuka
Morino, Saeko
Okuno, Hideo
Satoh, Hiroshi
Arai, Satoru
Mochizuki, Mie
Yamagata, Zentaro
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15mk0101005h0102)
Ministry of Education, Culture, Sports, Science and Technology (JP18K17376)
Japan Agency for Medical Research and Development (16mk0101012j0003)
Article History
Received: 11 November 2019
Revised: 25 March 2020
Accepted: 25 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: TN received honoraria from Daiichi Sankyo Co., Sanofi K.K. and Mitsubishi Tanabe Pharma Corporation. MMochizuki received honoraria from Pfizer Inc. MMori’s department received unrestricted research grants from AbbVie GK; Ayumi Pharmaceutical Corporation; Chugai Pharmaceutical Co., Ltd.; CSL Behring K.K.; Japan Blood Products Organization; Nippon Kayaku Co., Ltd.; UCB Japan Co., Ltd.; and Asahikasei Pharmaceutical Corporation. The other authors have no conflicts of interest to declare.
: The study protocol was reviewed and approved by the Ethics Committee of the National Institute of Infectious Diseases (the principal institution of this project) in accordance with the ethical guidelines and regulations of the Declaration of Helsinki (approval number: H27-561).
: Physicians in hospitals explained the study to their patients and obtained written informed consent from the parent(s) or legal guardian(s) of each child and/or assent by the child (when applicable) before initiating medical interview and record review.
Free to read: This content has been made available to all.